Status:
COMPLETED
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
To obtain information on clinical practices for patients treated by Aptivus in real life
Eligibility Criteria
Inclusion
- HIV positive patients for whom Aptivus treatment is initiated by their physician
- Aptivus SCP respect
Exclusion
- None if the inclusion criteria are respected: observational study
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00615290
Start Date
June 1 2007
Last Update
August 8 2014
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Agen, France
2
Boehringer Ingelheim Investigational Site
Aix-en-Provence, France
3
Boehringer Ingelheim Investigational Site
Amiens, France
4
Boehringer Ingelheim Investigational Site
Argenteuil, France